Latest posts tagged with #NAMD on Bluesky
#MedNews - Early retinal drying in people with neovascular age-related macular degeneration receiving #faricimab treatment may signal improved disease control that allows subsequent injection intervals to be extended.
Full story 👉 buff.ly/dJtmk3A
#EyeSky #nAMD
New TALON Phase IIIb results: brolucizumab enables more nAMD patients to reach 16-week treat-and-extend dosing vs aflibercept, with comparable vision gains—less treatment burden.
#nAMD #Retina #Ophthalmology #ClinicalTrials #MedTwitter #VisionResearch buff.ly/OI1TPGZ
Uso de GLP1RA en pacientes con diabetes se asocia con un riesgo 2 veces mayor de desarrollar degeneración macular neovascular asociada con la edad #glp1ras #nAMD #diabetes jamanetwork.com/journals/jam...
What are the mechanisms and risk factors for fibrosis in #nAMD?
Understand what is driving this common end-stage phenomenon, and the limitations of current detection methods.
👉 buff.ly/B3OtyXB
#EyeSky
#MedNews - #Aflibercept provides sustained visual acuity for up to 2 years in patients with #nAMD when given at a dose of 8 mg every 12 or 16 weeks.
Full story 👉https://buff.ly/o2TNBm9
#EyeSky
From #EURETINA25 - Faricimab 6 mg and aflibercept 8 mg may offer the best balance between visual and anatomical outcomes and treatment burden in neovascular age-related macular degeneration.
👉https://buff.ly/tEriVcQ
#EyeMed #MedNews #nAMD
❗ LAST CHANCE TO REGISTER ❗
Join our experts to explore the groundbreaking advances in retinal imaging and gene therapy, before taking a deep dive into emerging treatments for #nAMD.
Register now 👉 buff.ly/BSZphUA
#EyeSky #EyeMed #MedEd
#MedNews - Risk of new-onset neovascular age-related macular degeneration in patients with #diabetes more than doubles with use of #GLP1 receptor agonists for 6 months.
Full story 👉 buff.ly/UqdYPAB
#EyeMed #nAMD
#NeovascularAgerelatedMacularDegeneration #nAMD
APEX1 redox-specific inhibitor APX2009 (intravitreal) ⏬🐭👁️pathological #Angiogenesis
Laser-induced #ChoroidNeoVascularization
Vldlr-/- mouse subretinal neovascularization
Timothy Corson lab #Angiogenesis 2025
link.springer.com/article/10.1...
🚨 Applications are open for the 63rd Hands-on Workshop on Computational Biophysics at Auburn University!
📍 Auburn University | 📅 Aug 4–8, 2025
🔬 Learn #NAMD, #VMD from experts in #moleculardynamics
👩💻 In-person | Free to apply | 35 spots only
⏳ Deadline: June 20
🔗 aub.ie/Workshop2025
Are you using nonadiabatic dynamics for complex systems? Join us in sunny Spain for the "Future Directions in Non-Adiabatic Dynamics" workshop (Sept 2-5, 2025) at CECAM-Zaragoza! Register by June 3. Check out the event page: tinyurl.com/2nvnanf2
#NAMD #NonAdiabaticDynamics #CECAM
💻 Call for the Nonadiabatic Molecular Dynamics community!
We're working toward molecular benchmarks to navigate method selection. Our Roadmap is now on ArXiv, and we welcome your feedback!
📄 Read: arxiv.org/abs/2502.14569
📩 Send comments by 16/03
#NAMD #ComputationalChemistry #MolecularDynamics
👁️ Faricimab vs. anti-VEGF treatments for nAMD: Could it improve outcomes in Italy? @aboutscience.bsky.social
🔗 www.scienceopen.com/document?vid...
#nAMD #ClinicalResearch
Starting now the 62nd Hands-on workshop on computational Biophysics ! Excited to share about intro and new updates on #namd and #VMD!
Today’s #JournalClub by Alessandro discusses ways to facilitate nonadiabatic dynamics #NAMD with #MachineLearning #DeelLearning, developed by Westermayr, Gonzalez, Dral, Cui, et al. #compchem www.h-its.org/research/ccc...
